Alan Robertson Selected Research

Estrogen Receptors

1/2019

LobSig is a multigene predictor of outcome in invasive lobular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan Robertson Research Topics

Disease

6	Neoplasms (Cancer) 01/2019 - 08/2009
2	Leukemia 01/2019 - 10/2016
1	Lobular Carcinoma 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Lymphoma (Lymphomas) 10/2016
1	Multiple Myeloma 10/2016
1	Adenocarcinoma 03/2016
1	Hyperglycemia 01/2014
1	Hypoglycemia (Reactive Hypoglycemia) 01/2014
1	Type 2 Diabetes Mellitus (MODY) 12/2012
1	Pyonephrosis 02/2010
1	Hydronephrosis 02/2010
1	Infections 02/2010
1	Pyelonephritis 02/2010
1	Sepsis (Septicemia) 02/2010
1	Syncope (Fainting) 01/2009

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2009
2	GlucokinaseIBA 01/2014 - 12/2012
2	Molecular Chaperones (Chaperone, Molecular)IBA 11/2012 - 08/2009
1	Estrogen ReceptorsIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	EnzymesIBA 01/2017
1	S63845IBA 10/2016
1	ChromatinIBA 03/2016
1	6- (3- cyclopentyl- 2- (4- (trifluoromethyl)- 1H- imidazol- 1- yl)propanamido)nicotinic acidIBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	LipidsIBA 01/2014
1	IndazolesIBA 12/2012
1	pyrazolopyridineIBA 12/2012
1	SolventsIBA 01/2009

Therapy/Procedure

1	Therapeutics 01/2019
1	Drug Therapy (Chemotherapy) 01/2019
1	Nephrotomy 02/2010
1	Decompression 02/2010
1	Stents 02/2010